- KYMR Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-1/A Filing
Kymera Therapeutics (KYMR) S-1/AIPO registration (amended)
Filed: 13 Aug 20, 9:05am
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated June 22, 2020, in Amendment No. 2 to the Registration Statement (Form S-1 No. 333-240264) and related Prospectus of Kymera Therapeutics, Inc. dated August 13, 2020.
/s/ Ernst & Young LLP
Boston, Massachusetts
August 13, 2020
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.